Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abramson Cancer Center at Penn Medicine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histoloically proven primary cancer of the oropharynx, p16(+) and/or HPV (+), who are planned for treatment with resection, radiation and/or chemotherapy.
Subsites of oropharynx:include tonsil, base of tongue, vallecula, oropharyngeal wall, soft palate, glossotonsillar sulcus.
No or minimal smoking history (\</= 10 pack-year, no smoking in the past 12 months last 10 years based on documented history and/or subject report)
Age 18 years or older
Subjects are capable of giving informed consent or have an acceptabl;e surrogate capable of giving consent on the subjects behalf.
Enrollment on any other study, regardless of therapy is allowed.
Enrollment on any other tumor or tissue banking study is allowed.
Patients who have had blood drawn as part of another study, including the IRB-approved ENT Tumor Bank Study, may be included in this study even if the patient has already had surgery.
You may not be if
Previous chemotherapy or radiation therapy to the head and neck unrelated to current disease.
Previous surgery for head and neck cancer unrelated to current disease.
Widespread , biopsy-proven metastatic disease (stage IVC disease) at time of presentation (small indeterminate lung or mediastinal nodules are allowed)
Patients who have started induction chemotherapy prior to consideration for study eligibility.
Another active cancer except nonmelanomatous skin cancer.
History of cervical penile or anal cancer.
Patient treated with surgery, adjuvant radiation therapy or chemotherapy outside of the University of Pennsylvania.
History of smoking in the past last 12 months 10 years
History of 10 pack-years of cigarette smoking based on documented history and/or subject report
Presence of sidespread leukoplakia or erythroplakia.
Clareo Health | HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
